tiprankstipranks
Trending News
More News >
Whitehawk Therapeutics (WHWK)
NASDAQ:WHWK
US Market

Whitehawk Therapeutics (WHWK) Financial Statements

Compare
498 Followers

Whitehawk Therapeutics Financial Overview

Whitehawk Therapeutics's market cap is currently $184.54M. The company's EPS TTM is $-0.34; its P/E ratio is -7.27; Whitehawk Therapeutics is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 7.14M$ 25.98M$ 24.35M$ 15.22M$ 1.12M
Gross Profit$ 6.38M$ -28.07M$ -27.38M$ -18.78M$ -18.55M
Operating Income$ -114.40M$ -67.46M$ -71.93M$ -62.68M$ -111.22M
EBITDA$ -114.40M$ -64.63M$ -71.76M$ -58.80M$ -36.96M
Net Income$ -20.60M$ -63.69M$ -65.77M$ -60.51M$ -110.09M
Balance Sheet
Cash & Short-Term Investments$ 145.70M$ 47.24M$ 108.84M$ 172.56M$ 148.99M
Total Assets$ 150.83M$ 70.32M$ 132.42M$ 184.24M$ 157.91M
Total Debt$ 0.00$ 833.00K$ 1.27M$ 1.66M$ 605.00K
Net Debt$ -37.57M$ -27.84M$ -61.62M$ -37.36M$ -148.38M
Total Liabilities$ 14.52M$ 17.84M$ 27.23M$ 25.86M$ 21.50M
Stockholders' Equity$ 136.31M$ 52.48M$ 105.19M$ 158.38M$ 136.41M
Cash Flow
Free Cash Flow$ -97.98M$ -61.20M$ -63.63M$ -50.08M$ -22.47M
Operating Cash Flow$ -97.43M$ -59.55M$ -59.66M$ -49.64M$ -22.42M
Investing Cash Flow$ 11.89M$ 25.20M$ 83.21M$ -132.89M$ 25.15M
Financing Cash Flow$ 94.38M$ 130.00K$ 326.00K$ 72.62M$ 141.80M
Currency in USD

Whitehawk Therapeutics Earnings and Revenue History

Whitehawk Therapeutics Debt to Assets

Whitehawk Therapeutics Cash Flow

Whitehawk Therapeutics Forecast EPS vs Actual EPS